ICON Plc

ICON Plc ICON is a global provider of outsourced clinical research development services to the pharmaceutical, biotechnology, and medical device industries.

We help our clients accelerate the development of life-saving drugs that improve patients' quality of life.

Despite funding challenges, optimism prevails.ICON’s 2025 Global biotech survey report shows sustained confidence in inv...
16/03/2026

Despite funding challenges, optimism prevails.
ICON’s 2025 Global biotech survey report shows sustained confidence in investment delivery and product success.

92% confident in meeting milestones
91% expect product success

Learn what drives this confidence: https://ow.ly/Hhb550YiEHk

83% of biotech leaders in China plan to increase R&D spending in the next 1–2 years.China’s biotech sector continues to ...
13/03/2026

83% of biotech leaders in China plan to increase R&D spending in the next 1–2 years.
China’s biotech sector continues to expand, with accelerated regulatory timelines and growing collaboration shaping R&D strategy.

Explore how China’s biotech ecosystem is influencing global research: https://ow.ly/S4GR50Yra93

Antibody-drug conjugates are transforming cancer treatment, but their complexity demands a clear and forward-looking reg...
13/03/2026

Antibody-drug conjugates are transforming cancer treatment, but their complexity demands a clear and forward-looking regulatory strategy.

In this new BioSpectrum Asia article, ICON experts break down the evolving global framework for ADC approvals and the pathways that can accelerate access for patients.
Read more: https://ow.ly/sANX50YnYEw

Quality by design and risk based thinking now sit at the centre of modern clinical data science. From digitised protocol...
13/03/2026

Quality by design and risk based thinking now sit at the centre of modern clinical data science. From digitised protocols to agentic AI, the field is more proactive, connected and patient-focused than ever. In this blog, Luke Gregory explores the trends shaping the future of clinical data science: https://ow.ly/wl3z50Yse12

How to navigate EU MAA Regulations and Registration. For Chinese pharma and biotech companies looking to expand into the...
12/03/2026

How to navigate EU MAA Regulations and Registration. For Chinese pharma and biotech companies looking to expand into the European Union’s market of over 450 million people, the first step is to understand the significant regulatory requirement differences. These are far reaching – from timelines to transparency rules, communication style and processes. Failure to fully understand and adhere to these requirements will lead to delays, costing unnecessary money and time delays.

To set yourself up for success, download your copy now. https://ow.ly/TZKo50Xz22B

Latest issue out now. Keep up to date on the latest changes with ICON’s Regulatory Intelligence Newsletter. Join thousan...
12/03/2026

Latest issue out now.

Keep up to date on the latest changes with ICON’s Regulatory Intelligence Newsletter. Join thousands of subscribers who have discovered the convenience of this free monthly publication by signing up today: https://ow.ly/UehM50YlPXp

Compiled and collated by ICON’s Regulatory Intelligence Team and delivered monthly to your inbox, it provides the overview you need, with convenient links to the detailed sources. Stay ahead of the dynamic and ever-changing world of clinical trial regulations by signing up today!

Attending on 17-21 March? Visit us at booth #29 to learn how ICON is accelerating CNS trials and helping to drive col...
12/03/2026

Attending on 17-21 March? Visit us at booth #29 to learn how ICON is accelerating CNS trials and helping to drive collaboration across advocacy groups, biotech, pharma, and regulators. https://ow.ly/Abvc50Y8Fa0

We're pleased to share highlights of our ongoing CSR initiatives in Chennai.Colleagues from ICON's India team recently j...
12/03/2026

We're pleased to share highlights of our ongoing CSR initiatives in Chennai.

Colleagues from ICON's India team recently joined a Plantation Drive at SOS Children's Village, planting over 50 saplings as part of our ongoing commitment to environmental sustainability and community engagement.

It's one of many ways our teams are living out ICON's commitment to strengthening the communities in which we live and work.

Human ADME studies are essential for understanding how investigational drugs are absorbed, distributed, metabolised and ...
11/03/2026

Human ADME studies are essential for understanding how investigational drugs are absorbed, distributed, metabolised and excreted. Yet traditional sampling—limited to plasma, urine and faeces- leaves a key blind spot: biliary excretion.

Minimally invasive techniques such as the Entero‑Tracker bile string and nasoduodenal sampling now help fill this gap, providing clearer mechanistic insight in early‑phase trials. Read the full blog to see how bile sampling is reshaping human ADME and unlocking deeper understanding of drug behaviour. https://ow.ly/x31k50YmiB2

Join ICON’s Dr. Anne Behringer on 25 March at 03:00 for a virtual presentation on “Cross-Border Recruitment in Clinical ...
11/03/2026

Join ICON’s Dr. Anne Behringer on 25 March at 03:00 for a virtual presentation on “Cross-Border Recruitment in Clinical Trials: A Perspective on Operational Reality”. Learn more https://ow.ly/blwJ50Yr92Q

11/03/2026

Which modalities dominate global biotech pipelines?
ICON’s 2025 Global biotech survey report highlights where global sponsors are focusing R&D efforts and how these choices shape long‑term investment planning.

Cell therapy leads globally at 40%, followed by ADCs and microbiome therapies at 31%.

See the full pipeline breakdown: https://ow.ly/JSNc50Yra6L

From feasibility to activation, study start-up delays can erode momentum and inflate costs. ICON’s Brian Mallon offers p...
10/03/2026

From feasibility to activation, study start-up delays can erode momentum and inflate costs. ICON’s Brian Mallon offers perspective and outlines practical fixes, including AI-driven contracting, early site engagement, and strategic site selection. https://ow.ly/2vst50Ymhev

Address

South County Business Park, Leopardstown
Dublin
18

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+35312912000

Website

Alerts

Be the first to know and let us send you an email when ICON Plc posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ICON Plc:

Shortcuts

Featured

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category